The effect of interleukin-1α on outflow facility in rat eyes

Journal of Glaucoma

Volumn 6, Issue 4, 1997, Pages 246-249

  Kee, Changwon ^a,b   Seo, Kangmoon ^b  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Albino rat eye; Interleukin 1 ; Outflow facility; Outflow resistance; Trabecular extracellular matrix

Indexed keywords

BOVINE SERUM ALBUMIN; INTERLEUKIN 1ALPHA; METALLOPROTEINASE; PENTOBARBITAL; SODIUM CHLORIDE; INTERLEUKIN 1;

ALBINISM; ANIMAL EXPERIMENT; AQUEOUS HUMOR OUTFLOW; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXTRACELLULAR MATRIX; FEMALE; INTRACAMERAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRABECULAR MESHWORK; TURNOVER TIME; ANIMAL; ANTERIOR EYE CHAMBER; AQUEOUS HUMOR; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANTERIOR CHAMBER; AQUEOUS HUMOR; EXTRACELLULAR MATRIX; FEMALE; INTERLEUKIN-1; MALE; RATS; RATS, SPRAGUE-DAWLEY; TRABECULAR MESHWORK;

EID: 0030611847     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bárány EH, Scotchbrook S. Influence of testicular hyaluronidase on the resistance to flow through the angle of the anterior chamber. Acta Physiol Scand 1954;30:240-8.
2. Francis J. The importance of mucopolysaccharides in intraocular pressure regulation. Invest Ophthalmol Vis Sci 1975;14:173-6.
3. Lütjen-Drecoll E, Rohen JW. Pathology of the trabecular meshwork in primary open-angle glaucoma. In: Kaufman PL, Mittag TW, eds. Glaucoma. London: Mosby, 1994:8.37-39.
4. Acott TS, Kingsley PD, Samples JR, Van Buskirk EM. Human trabecular meshwork organ culture: morphology and glycosaminoglycan synthesis. Invest Ophthalmol Vis Sci 1988;29:90-100.
5. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992;14:455-63.
6. Edwards DR, Leco KJ, Beaudry PP, Atadja PW, Veillette C, Riabowol KT. Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts. Exp Gerontol 1996;31:207-23.
7. Fabunmi RP, Baker AH, Murray EJ, Booth RF, Newby AC. Divergent regulation by growth factors and cytokines of 95 kDa and 72 KDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem J 1996; 315:335-42.
8. Alvares O, Klebe R, Grant G, Cochran DL. Growth factor effects on the expression of collagenase and TIMP-1 in periodontal ligament cells. J Periodontol 1995;66:552-8.
9. Yamamoto H, Itoh F, Senota A, et al. Expression of matrix metalloproteinase matrilysin(MMP-7) was induced by activated Kiras via AP-1 activation in SW1417 colon cancer cells. J Clin Lab Anal 1995;9:297-301.
10. Kylmaniemio M, Autio P, Oikarinen A. Influence of aging, localization, glucocorticoids and isotretinoin on matrix metalloproteinases 2 and 9 in suction blister fluids. Arch Dermatol Res 1995; 287:434-8.
11. Pan L, Eckhoff C, Brinckerhoff CE. Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs. J Cell Biochem 1995; 57:575-89.
12. de Bart AC, Quax PH, Lowik CW, Verheijen JH. Regulation of plasminogen activation matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha. J Bone Miner Res 1995;10:1374-84.
13. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Bio Chem Hoppe-Seyler 1995;376:345-55.
14. Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 1992;12:168-84.
15. Samples JR, Alexander JP, Acott TS. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone. Invest Ophthalmol Vis Sci 1993; 34:3386-95.
16. Bradley JMB, Conger DM, Fisk AS, Samples JR, Acott TS. Matrix metalloproteinases increase outflow facility in perfused anterior segment explants. [ARVO Abstracts]. Invest Ophthalmol Vis Sci 1995;36:S727.
17. Kee C, Choi K. A delicate ocular perfusion apparatus measuring outflow facility. Vision Res 1996;36:S148.
18. Ethier CR, Ajersch P, Pirog R. An improved ocular perfusion system. Curr Eye Res 1993;12:765-70.
19. Alexander JP, Samples JR, Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci 1991;32:172-80.
20. Parshley DE, Bradley JBM, Samples JR, Van Buskirk EM, Acott TS. Early changes in matrix metalloproteinases and inhibitors after in vitro laser treatment to the trabecular meshwork. Curr Eye Res 1995;14:537-44.